Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings

Tuberculosis (TB) is still considered a deadly disease, ranked 10th in the top 10 list of lethal diseases worldwide. But the drug-resistant form of TB is more fatal and complex. It is evident that such drug-resistant TB should be detected as early as possible so that the doctors can provide accurate...

Full description

Bibliographic Details
Main Authors: Abhishek Paul, Nirmita Dutta, Despina Moschou, Gorachand Dutta
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2020-01-01
Series:Sensors International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S266635112030036X
id doaj-2a77295b31674aa6adf84e2479dc22cb
record_format Article
spelling doaj-2a77295b31674aa6adf84e2479dc22cb2021-04-02T16:33:14ZengKeAi Communications Co., Ltd.Sensors International2666-35112020-01-011100036Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settingsAbhishek Paul0Nirmita Dutta1Despina Moschou2Gorachand Dutta3School of Medical Science and Technology (SMST), Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, 721302, IndiaSchool of Medical Science and Technology (SMST), Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, 721302, IndiaCentre for Biosensors, Bioelectronics and Biodevices (C3Bio), Department of Electronic & Electrical Engineering, University of Bath, Bath BA2 7AY, UKSchool of Medical Science and Technology (SMST), Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, 721302, India; Corresponding author.Tuberculosis (TB) is still considered a deadly disease, ranked 10th in the top 10 list of lethal diseases worldwide. But the drug-resistant form of TB is more fatal and complex. It is evident that such drug-resistant TB should be detected as early as possible so that the doctors can provide accurate and effective treatment to the infected patient, and thus prevent transmission. Many diagnostic methods for different types of drug-resistant TB have been developed, some of which are approved by WHO, while some are not. The following review highlights different methods for the rapid, accurate and sensitive detection of drug-resistant TB (DR-TB) and also discusses the potential of those methods for point-of-care (POC) application.http://www.sciencedirect.com/science/article/pii/S266635112030036XTuberculosisDrug-resistantBiosensorMicrofluidicPoint-of-care
collection DOAJ
language English
format Article
sources DOAJ
author Abhishek Paul
Nirmita Dutta
Despina Moschou
Gorachand Dutta
spellingShingle Abhishek Paul
Nirmita Dutta
Despina Moschou
Gorachand Dutta
Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings
Sensors International
Tuberculosis
Drug-resistant
Biosensor
Microfluidic
Point-of-care
author_facet Abhishek Paul
Nirmita Dutta
Despina Moschou
Gorachand Dutta
author_sort Abhishek Paul
title Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings
title_short Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings
title_full Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings
title_fullStr Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings
title_full_unstemmed Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings
title_sort advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings
publisher KeAi Communications Co., Ltd.
series Sensors International
issn 2666-3511
publishDate 2020-01-01
description Tuberculosis (TB) is still considered a deadly disease, ranked 10th in the top 10 list of lethal diseases worldwide. But the drug-resistant form of TB is more fatal and complex. It is evident that such drug-resistant TB should be detected as early as possible so that the doctors can provide accurate and effective treatment to the infected patient, and thus prevent transmission. Many diagnostic methods for different types of drug-resistant TB have been developed, some of which are approved by WHO, while some are not. The following review highlights different methods for the rapid, accurate and sensitive detection of drug-resistant TB (DR-TB) and also discusses the potential of those methods for point-of-care (POC) application.
topic Tuberculosis
Drug-resistant
Biosensor
Microfluidic
Point-of-care
url http://www.sciencedirect.com/science/article/pii/S266635112030036X
work_keys_str_mv AT abhishekpaul advancedintegrativesensingtechnologiesfordetectionofdrugresistanttuberculosisinpointofcaresettings
AT nirmitadutta advancedintegrativesensingtechnologiesfordetectionofdrugresistanttuberculosisinpointofcaresettings
AT despinamoschou advancedintegrativesensingtechnologiesfordetectionofdrugresistanttuberculosisinpointofcaresettings
AT gorachanddutta advancedintegrativesensingtechnologiesfordetectionofdrugresistanttuberculosisinpointofcaresettings
_version_ 1721556226690514944